Saks Fifth Avenue Key to the Cure fundraiser, which benefits the cancer research programs of the Louisiana Cancer Research Consortium, will take place this year Oct. 18-21, with a kickoff gala Oct. 17. The LCRC is a cancer research partnership between LSUHSC and Ochsner, and Tulane and Xavier universities. Over the past 11 years, Saks Fifth Avenue’s Key to the Cure has generated more than $1 million to assist local scientists in their ongoing quests to find cures.
LSUHSC’s Louisiana Tumor Registry, a program of the university’s School of Public Health, recently accepted the 20th anniversary Research Award from the National Program of Cancer Registries. Only two of these awards are given annually, recognizing the institution and researchers who best utilized central cancer registry data for research. Currently collaborating with multiple states in several projects addressing the treatment effectiveness for localized prostate cancer and its impact on the quality of life (CEASAR Study), researchers are also examining detailed treatments for cancers of the breast, colon and rectum, as well as chronic myeloid leukemia and assessing their comparative effectiveness (CER Project), validating the instrument in collecting data on the quality of life and patient outcomes in minority populations (MY-Health study), and conducting causative studies on multiple myeloma and ovarian cancer among African Americans.
Ochsner Medical Center was recognized by Becker’s Hospital Review as one of the “100 Hospitals with Great Orthopedic Programs.” Hospitals included on this list focus on orthopedics and their orthopedic surgery departments and have outstanding reputations. “This is a testament to the commitment to quality that each member of our orthopedics team exemplifies,” says Michael Hulefeld, CEO of Ochsner Medical Center. “It is our continuing mission to bring this type of high-level service to the city of New Orleans and surrounding areas.” The editorial team at Becker’s arrived at their decision to award Ochsner after they analyzed, scored and weighed data from outside sources on factors that include patient-centered care, forward-thinking research and continual innovation in orthopedic treatments and services.